NCT06698822
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
701 public trials
104 recruiting studies
Lymphoma, T-Cell trial results
NCT05833724
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
- Far eastern memorial hospital New Taipei City, Taiwan
- Taichung Veterans General Hospital Taichung, Taiwan
NCT06860880
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- North Carolina Basnight Cancer Hospital Chapel Hill, North Carolina, United States
Recruiting
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
NCT04256018
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Stanford Cancer Center Stanford, California, United States
Recruiting
Registry of Older Patients With Cancer
NCT01137825
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
- Locations
-
- Seby B. Jones Cancer Center Boone, North Carolina, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
- East Carolina University Greenville, North Carolina, United States
- Pardee Cancer Center Hendersonville, North Carolina, United States
NCT04068597
- Conditions
- Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +27 more
- Locations
-
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- Community Health Network Indianapolis, Indiana, United States
- The Center for Cancer and Blood Disorders (CCBD) Bethesda, Maryland, United States
- Nebraska Cancer Specialists Omaha, Nebraska, United States
NCT07502768
- Conditions
- Disease Attributes, Extranodal NK/T-cell Lymphoma, Lymphoma, +10 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
NCT05475925
- Conditions
- Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
- Locations
-
- Dren Investigational Site Birmingham, Alabama, United States
- Dren Investigational Site Duarte, California, United States
- Dren Investigational Site Irvine, California, United States
- Dren Investigational Site Redwood City, California, United States
Recruiting
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
NCT07234162
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Anhui Provincial Cancer Hospital Hefei, Anhui, China
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Beijing Tongren Hospital, CMU Beijing, Beijing Municipality, China
NCT07624838
- Conditions
- CD30-Positive Peripheral T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Hospital Universitario A Coruña A Coruña, Spain
- Hospital Universitari Son Llàtzer Palma de Mallorca, Balearic Islands, Spain
- Hospital Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
- ICO Hospital Germans Trias i Pujol Badalona, Barcelona, Spain